Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Verruca VulgarisMolluscum Contagiosum Skin Infection
Interventions
DEVICE

Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)

The treatment device in this study generates cold atmospheric plasma. Cold atmospheric plasma has certain properties of plasma, such as ionized gas molecules. To create plasma, a pulse generator supplying 20 kilovolt pulse of 20-ns pulse width at 200 Hz (FPG10-01NM10, FID GmbH, Burbach, Germany) to a 5-mm diameter quartz-covered copper electrode of 10-cm length and 1 - 13mm quartz thickness. These nanosecond pulse parameters were chosen to provide sufficient treatment dose at the high level of plasma uniformity required to avoid any tissue damage. We will treat the lesions for approximately 1 to 2 minutes each, moving the electrode gently over the treatment area.

DEVICE

Cryotherapy

Cryotherapy refers to the application of liquid nitrogen using a cryospray device in order to freeze a lesion of interest. Treatment is repeated every few weeks until the lesion of interest has disappeared. It is considered SOC for the treatment of warts.

DRUG

Canthardin Collodion

Chemical compound that acts as a vesicant to form a blister around treatment area. The blister lifts the lesion of interest away from the skin, causing it to slough off in a few days. It is used as SOC for the treatment of Molluscum Contagiosum.

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
collaborator

The Skin Center Dermatology Group

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT05070754 - Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca | Biotech Hunter | Biotech Hunter